Fresenius Medical Care AG (FMS)

NYSE: FMS · USD

$22.6

+0.09 (+0.4%)· Recorded snapshot

Market cap	12B
Revenue (ttm)	22.2B
Net income (ttm)	1.1B
EPS (ttm)	$1.86
Shares out	266.1M
P/E (trailing)	12.1x
P/E (forward)	10.8x
Dividend	$0.61 (2.69%)
Volume	664,929
Beta	0.81

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 22.2B
Net income (ttm): 1.1B
EPS (ttm): $1.86
P/E (trailing): 12.1x
P/E (forward): 10.8x
Market cap: 12B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Conserver

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E10.8

P25 n/aP50 n/aP75 n/a

Trailing P/E12.1

P25 n/aP50 n/aP75 n/a

ROE8.5

P25 n/aP50 n/aP75 n/a

ROIC6.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All FMS indicators

Market & fundamental data

Available fields

279

Groups with data

Currency

EUR

Showing 279 of 279 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001333141
Company name	Fresenius Medical Care AG
Country	Germany
Country code	US
CUSIP number	358029106
Earnings date	2026-11-03
Earnings time	bmo
Employees	107,226
Employees change	-5,219
Employees growth	-4.64%
Enterprise value	$24.2B
Exchange	NYSE
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1996
Industry	Medical Care Facilities
IPO date	1996-09-19
Is primary listing	No
Is SPAC	No
ISIN number	US3580291066
Last 10-K release date	2026-02-24
Last earnings date	2026-08-03
Last refreshed	2026-10-28
Last stock split date	2012-12-04
Last stock split type	Forward
Market cap	$12B
Market cap category	Large-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$22.59
Price currency	USD
Sector	Healthcare
SIC code	8090
Stock price date	2026-10-28
Symbol	FMS
Website	https://www.freseniusmedicalcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	4.42x
Average P/E ratio (10Y)	17.72x
Average P/E ratio (3Y)	18.9x
Average P/E ratio (5Y)	18.31x
Earnings yield	8.25%
EV/Earnings	22.52x
EV/EBIT	10.6x
EV/EBITDA	7.76x
EV/FCF	12.13x
EV/Sales	1.09x
FCF / EV yield	8.25%
FCF yield	16.59%
Forward EV/Sales	1.09x
Forward P/E	10.81x
Forward P/S	0.54x
Graham number	36.2647
Graham upside	60.96%
Industry forward P/E	14.81x
Industry P/E	18.21x
Lynch fair value	$10.06
Lynch upside	-55.33%
P/B ratio	0.78x
P/E ratio	12.11x
P/FCF ratio	6.03x
P/OCF ratio	3.8x
P/S ratio	0.54x
Price/EBITDA ratio	3.86x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	10.26%
EBITDA margin	14.01%
Effective tax rate	20.93%
FCF margin	9.19%
Gross margin	26.36%
Operating margin	10.26%
Pretax margin	7.73%
Profit margin	4.83%
Profit per employee	$9,992
Profitable quarters	86
Profitable years	23
Revenue per employee	$206,991
ROA	3.98%
ROA (5Y)	3.11%
ROCE	8.26%
ROE	8.52%
ROE (5Y)	6.59%
ROIC	6.64%
ROIC (5Y)	4.94%
Tax / revenue	1.62%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	49.98%
EPS growth (Q)	5.5%
EPS growth (QoQ)	89.7%
EPS growth 10Y	0.22%
EPS growth 3Y	18.11%
EPS growth 5Y	-0.38%
EPS growth quarters	1
EPS growth years	2
FCF growth	-12.85%
FCF growth (Q)	-0.1%
FCF growth (QoQ)	1,583.56%
FCF growth 3Y	1.24%
FCF growth 5Y	3.36%
Gross profit growth	6.34%
Gross profit growth (Q)	7.87%
Gross profit growth 3Y	2.03%
Gross profit growth 5Y	-0.41%
Net income growth	42.86%
Net income growth (Q)	-3.06%
Net income growth (QoQ)	85.81%
Net income growth 3Y	16.33%
Net income growth 5Y	-1.24%
Net income growth years	2
OCF growth	2.77%
OCF growth (Q)	11.02%
OCF growth (QoQ)	279.18%
OCF growth 10Y	4.73%
OCF growth 3Y	5.55%
OCF growth 5Y	2.86%
Operating income growth	26.09%
Operating income growth (Q)	32.77%
Operating income growth 3Y	9.03%
Operating income growth 5Y	-0.48%
Revenue growth	-0.47%
Revenue growth (Q)	1.44%
Revenue growth (QoQ)	5.39%
Revenue growth 10Y	2.06%
Revenue growth 3Y	-0.33%
Revenue growth 5Y	2.29%
Revenue growth quarters	1
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-1.2B
Depreciation and amortization	$812.5M
EBIT	$2.3B
EBITDA	$3.1B
EPS	$1.86
FCF per share	$7.48
Financing cash flow	$-2.9B
Free cash flow	$2B
Gross profit	$5.8B
Income taxes	$359M
Investing cash flow	$-1B
Net borrowing	$-537.4M
Net cash flow	$-752.8M
Net income	$1.1B
Operating income	$2.3B
Revenue	$22.2B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.78
Book value per share	$53.91
Debt / EBITDA	3.27
Debt / equity	0.81
Debt / FCF	6.3
Goodwill	$15.6B
Interest coverage	5.2
Long-term assets	$27.2B
Long-term liabilities	$12.3B
Net cash (debt)	$-11.3B
Net cash / market cap	-94.47%
Net debt / EBITDA	3.64
Net debt / equity	0.73
Net debt / FCF	5.69
Piotroski F-Score	7
Property, plant and equipment	$7.2B
Shareholders' equity	$15.5B
Tangible book value	$-3.1B
Tangible book value per share	$-11.55
Total assets	$35.8B
Total cash	$1.2B
Total debt	$12.5B
Total liabilities	$20.3B
WACC	5.65%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.62
Current assets	$8.6B
Current liabilities	$8B
Current ratio	1.07
Inventory turnover	6.61
Net working capital	$2B
Quick ratio	0.63
Working capital	$584.6M
Working capital turnover	14.86

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	4.44%
Dividend growth	6.38%
Dividend growth (10Y)	6.85%
Dividend growth (3Y)	13.44%
Dividend growth (5Y)	-10.75%
Dividend growth years	2
Dividend payment date	2026-06-08
Dividend payment years	28
Dividend payout frequency	Annual
Dividend per share	$0.61
Dividend yield	2.69%
Ex-dividend date	2026-05-22
FCF payout ratio	8.08%
Last dividend	$0.61
Payout ratio	32.39%
Shareholder yield	7.13%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-44.33%
10Y return CAGR	-4.22%
10Y total return	-35.01%
150-day SMA	$22.83
15Y price change	-38.45%
15Y return CAGR	-1.89%
15Y total return	-24.94%
1D price change	0.4%
1M price change	-0.75%
1M total return	-0.75%
1W price change	5.18%
1W total return	5.18%
1Y price change	-17.21%
1Y return CAGR	-14.92%
1Y total return	-14.91%
20-day SMA	$21.90
200-day SMA	$22.87
20Y price change	-0.66%
20Y return CAGR	1.25%
20Y total return	28.13%
3M price change	-9.45%
3M total return	-9.45%
3Y price change	37.32%
3Y return CAGR	13.66%
3Y total return	46.83%
50-day SMA	$22.42
50-day SMA vs 200-day SMA	50under200
52-week high	$27.40
52-week high date	2025-10-29
52-week low	$20.02
52-week low date	2026-05-05
5Y price change	-34.63%
5Y return CAGR	-6.27%
5Y total return	-27.66%
6M price change	-0.44%
6M total return	2.32%
All-time high	$57.94
All-time high date	2018-01-31
All-time low	$3.35
All-time low date	2002-09-19
Average true range (ATR)	$0.48
Average volume	1.2M
Beta (5Y)	0.81
Change from 52-week high	-17.55%
Change from 52-week low	12.84%
Change from all-time high	-61.13%
Change from all-time low	572.24%
Change from open	0.49%
Day's gap	-0.09%
Dollar volume	$15M
High price	$22.69
Low price	$22.45
Monthly RSI	47.05
Open price	$22.48
Position in 52-week range	58.33%
Premarket change	0.04%
Premarket close	$22.50
Premarket price	$22.51
Premarket volume	2.4K
Previous close	$22.50
Price vs 150-day SMA	-1.36%
Price vs 20-day SMA	2.85%
Price vs 200-day SMA	-1.51%
Price vs 50-day SMA	0.45%
Relative volume	0.54
RSI	54.54
Sharpe ratio	-0.51
Sharpe ratio (3Y)	0.38
Sharpe ratio (5Y)	-0.18
Sortino ratio	-0.47
Sortino ratio (3Y)	0.72
Sortino ratio (5Y)	-0.08
Volume	664.9K
Weekly RSI	47.42
YTD price change	-5.46%
YTD total return	-2.84%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	197.8M
Float percentage	74.31%
Shares change (QoQ)	-2.47%
Shares change (YoY)	-4.44%
Shares held by insiders	0.04%
Shares held by institutions	47.95%
Shares outstanding	266.1M
Short % of shares	0.2%
Short ratio	3.9 days

Deeper analysis on FMS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this FMS report

Is a complete FMS research report available?

No complete published report is available for Fresenius Medical Care AG (FMS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Fresenius Medical Care AG (FMS)

Price

Financial snapshot

Fair-value bridge

Latest news · FMS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FMS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on FMS

Frequently asked questions